Scopus Biopharma Inc (SCPS) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Scopus Biopharma Inc   (SCPS)


Scopus Biopharma Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Scopus Biopharma Inc's ROI in the second quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Scopus Biopharma Inc 's return on investment (ROI) in its second quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM - - - - 32.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -12 -8 -8 -6 -4
Return On Investment (TTM) - - - - -
SCPS's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -76.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -9 -10 -12 -16 -16

SCPS Company Profile >> Back to SCPS Roi Comparisons >> See Annual SCPS Return On Investment



Return On Investment SCPS's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Scopus Biopharma Inc's II. Quarter Investments $ -12 Millions SCPS's Balance sheet
Scopus Biopharma Inc's II. Quarter Income $ -3 Millions Quarterly SCPS's Income Statement
SCPS's Income by Division See SCPS's Income by Division


SCPS Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020

Total Investments in Millions -8 4 -2 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -12 -27 -11 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -670.91 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SCPS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SCPS's Competitors
Subscribers only: Roi for Scopus Biopharma Inc's Suppliers
Subscribers only: Return On Investment for SCPS's Customers

Other Ratios
SCPS's Roa SCPS's Inventory Turnover Ratio SCPS's Growth Rates SCPS's Dividend Statistics
SCPS's Profitability Ratios SCPS's Asset Turnover Ratio SCPS's Dividend Growth
SCPS's Roe SCPS's Valuation Ratios SCPS's Financial Strength Ratios SCPS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Therapeuticsmd Inc   226.36 %
Theravance Biopharma inc   220.74 %
Ir med Inc   205.47 %
Tff Pharmaceuticals Inc  168.69 %
Avalo Therapeutics Inc   149.88 %
Inhibitor Therapeutics Inc   143.07 %
Molecular Templates Inc   105.40 %
Chimerix Inc   71.97 %
Intercept Pharmaceuticals inc   66.44 %
Biomx Inc  64.84 %
Dariohealth Corp   55.27 %
Kiniksa Pharmaceuticals International Plc  55.10 %
Opus Genetics Inc   54.45 %
Scynexis Inc   53.53 %
Star Equity Holdings Inc   50.28 %
Fuse Medical Inc   49.21 %
Voyager Therapeutics Inc   48.99 %
Idexx Laboratories Inc  46.22 %
Shockwave Medical Inc   41.08 %
Entera Bio Ltd   40.58 %
Zymeworks Inc   40.51 %
Medpace Holdings Inc   40.02 %
Gyre Therapeutics Inc   39.45 %
Cv Sciences Inc   38.71 %
Revelation Biosciences Inc   37.76 %
Vaso Corporation  36.33 %
Mettler toledo International Inc   35.12 %
Tenax Therapeutics Inc   35.08 %
Catalyst Pharmaceuticals Inc   34.24 %
Enzo Biochem Inc  33.97 %

Date modified: 2026-08-29T17:42:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.